Fatigue and Assessment Methods in Neurological Disease

Öz

Fatigue, which is frequently seen in neurological diseases, is a symptom that restricts the daily life activities of individuals and leads to a decrease in their quality of life. In the subjective evaluation of fatigue, many scales have been developed to investigate dimensions such as the severity of fatigue, its effects on daily life activities, and its social, cognitive, and psychological effects. Scales developed to measure fatigue specific to neurological diseases are inadequate in number. Most of the scales used to evaluate fatigue in neurological diseases have been developed to evaluate fatigue in different populations. Invasive methods and non-invasive physiological tests are used in the objective evaluation of fatigue. Blood test and muscle biopsy are invasive methods which used in the evaluation of fatigue. The need for good muscle activation in evaluating fatigue with non-invasive physiological tests such as electromyography is a factor limiting the use of these methods in neurological diseases. However, the fact that fatigue is a symptom that can exist independently of activity in neurological diseases and its subjective nature shows that objective assessment methods do not provide sufficient information about fatigue in neurological diseases. For these reasons, it is necessary to develop fatigue assessment tools specially developed for neurological diseases, which take into account the nature of the disease, factors affecting fatigue and pathology, and good psychometric properties. Studies on this subject will benefit clinicians and researchers working in the field of neurological rehabilitation.

Anahtar Kelimeler

• Fatigue
• neurological disorders
• measurement

Nörolojik Hastalıklarda Yorgunluk ve Değerlendirme Yöntemleri

Öz

Nörolojik hastalıklarda sıklıkla görülen yorgunluk, bireylerin günlük yaşam aktivitelerinin kısıtlanmasına ve yaşam kalitelerinin azalmasına yol açan bir semptomdur. Yorgunluğun sübjektif değerlendirilmesinde yorgunluğun şiddeti, günlük yaşam aktiviteleri üzerine etkileri, sosyal, bilişsel ve psikolojik etkileri gibi boyutlarının araştırılması amacıyla birçok ölçek geliştirilmiştir. Nörolojik hastalıklara özgü yorgunluğu ölçmek için geliştirilmiş ölçekler sayıca yetersizdir. Nörolojik hastalıklarda yorgunluğu değerlendirmek amacıyla kullanılan ölçeklerin çoğu farklı popülasyonlarda yorgunluğu değerlendirmek için geliştirilmiştir. Yorgunluğun objektif olarak değerlendirilmesinde ise invaziv yöntemler ve invaziv olmayan fizyolojik testler kullanılmaktadır. Kan testi ve kas biyopsisi yorgunluğun değerlendirilmesinde kullanılan invaziv yöntemlerdendir. Elektromiyografi gibi invaziv olmayan fizyolojik testlerle yorgunluğun değerlendirilmesinde iyi derecede kas aktivasyonu gerekliliği, nörolojik hastalıklarda bu yöntemlerin kullanımını sınırlandıran bir faktördür. Bununla birlikte, nörolojik hastalıklarda yorgunluğun aktiviteden bağımsız olarak da var olabilen bir semptom olması ve sübjektif doğası objektif değerlendirme yöntemlerinin nörolojik hastalıklarda yorgunluk ile ilgili yeterli bilgi vermediğini göstermektedir. Bu nedenlerle, nörolojik hastalıklara özel geliştirilmiş, hastalığın doğasını, yorgunluğu etkileyen faktörleri ve patolojisini göz önünde bulunduran ve psikometrik özellikleri iyi olan yorgunluk değerlendirme araçlarının geliştirilmesi gerekmektedir. Bu konuda yapılacak olan çalışmalar, nörolojik rehabilitasyon alanında çalışan klinisyen ve araştırmacılara fayda sağlayacaktır.

Anahtar Kelimeler

• Yorgunluk
• nörolojik bozukluklar
• ölçüm

Kaynakça

1. Taylor JL, Gandevia SC. A comparison of central aspects of fatigue in submaximal and maximal voluntary contractions. Journal of Applied Physiology. 2008;104(2):542-50.
2. Zwarts M, Bleijenberg G, Van Engelen B. Clinical neurophysiology of fatigue. Clinical Neurophysiology. 2008;119(1):2-10.
3. Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy. Neurology. 2013;80(4):409- 16.
4. Jason LA, Evans M, Brown M, Porter N. What is fatigue? Pathological and nonpathological fatigue. PM&R. 2010;2(5):327-31.
5. De Vries J, Hagemans M, Bussmann J, Van der Ploeg A, Van Doorn P. Fatigue in neuromuscular disorders: Focus on Guillain–Barré syndrome and Pompe disease. Cellular and Molecular Life Sciences. 2010;67(5):701-13.
6. Ayache SS, Chalah MA. Fatigue in multiple sclerosis – Insights into evaluation and management. Neurophysiologie Clinique/Clinical Neurophysiology. 2017;47(2):139-71. doi: https://doi.org/10.1016/j.neucli.2017.02.004.
7. Cumming TB, Packer M, Kramer SF, English C. The prevalence of fatigue after stroke: A systematic review and meta-analysis. International Journal of Stroke. 2016;11(9):968-77. doi: 10.1177/1747493016669861. PubMed PMID: 27703065.
8. Siciliano M, Trojano L, Santangelo G, De Micco R, Tedeschi G, Tessitore A. Fatigue in Parkinson’s disease: A systematic review and meta‐analysis. Movement Disorders. 2018;33(11):1712-23.

9. McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H. Prevalence of fatigue and depression in ALS patients and change over time. Journal of Neurology, Neurosurgery & Psychiatry. 2009;80(10):1146-9. doi: 10.1136/jnnp.2008.163246.
10. Ruiter AM, Verschuuren JJGM, Tannemaat MR. Fatigue in patients with myasthenia gravis. A systematic review of the literature. Neuromuscular Disorders. 2020;30(8):631-9. doi: https://doi.org/10.1016/j.nmd.2020.06.010.
11. Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. American Journal of Hospice and Palliative Medicine. 2014;31(5):562-75. 12. Chaudhuri A, Behan PO. Fatigue in neurological disorders. The lancet. 2004;363(9413):978-88.
12. Aarnes R, Stubberud J, Lerdal A. A literature review of factors associated with fatigue after stroke and a proposal for a framework for clinical utility. Neuropsychological Rehabilitation. 2020;30(8):1449-76.
13. Weiland TJ, Jelinek GA, Marck CH, Hadgkiss EJ, van der Meer DM, Pereira NG, et al. Clinically significant fatigue: Prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One. 2015;10(2):e0115541.
14. Chen CT, Cheng K-Y, Chang W-N, Tsai N-W, Huang C-C, Kung C-T, et al. Clinical factors associated with fatigue in Parkinson’s disease. Neuropsychiatry. 2017;7(5):684–90.
15. Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, et al. Association between fatigue and other motor and non-motor symptoms in Parkinson’s disease patients. Journal of Neurology. 2014;261(2):382-91.
16. Penner I-K, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. 2017;13(11):662-75.
17. Wan J-j, Qin Z, Wang P-y, Sun Y, Liu X. Muscle fatigue: General understanding and treatment. Exp Mol Med. 2017;49(10):e384-e.
18. Newland P, Starkweather A, Sorenson M. Central fatigue in multiple sclerosis: A review of the literature. J Spinal Cord Med. 2016;39(4):386-99.
19. Davis MP, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8(4):164-74.
20. Kent-Braun JA. Central and peripheral contributions to muscle fatigue in humans during sustained maximal effort. Eur J Appl Physiol Occup Physiol. 1999;80(1):57-63.
21. Dobkin BH. Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments. Neurorehabil Neural Repair. 2008;22(2):105-10.
22. Rudroff T, Kindred JH, Ketelhut NB. Fatigue in multiple sclerosis: Misconceptions and future research directions. Front Neurol. 2016;7:122.
23. Abraham A, Drory VE. Fatigue in motor neuron diseases. Neuromuscular Disorders. 2012;22:S198-S202.
24. Lou J-S, Weiss MD, Carter GT. Assessment and management of fatigue in neuromuscular disease. American Journal of Hospice and Palliative Medicine. 2010;27(2):145-57.
25. Tyson SF, Brown P. How to measure fatigue in neurological conditions? A systematic review of psychometric properties and clinical utility of measures used so far. Clinical Rehabilitation. 2014;28(8):804-16.
26. Whitehead L. The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management. 2009;37(1):107- 28.
27. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: A practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157-70.
28. Rahman AN, Latir A, Manaf H. Fatigue after spinal cord injury: A systematic review of self-assessment instruments. Healthscope: The Official Research Book of Faculty of Health Sciences, UiTM. 2020;3(1):22-6.
29. Skogestad IJ, Kirkevold M, Indredavik B, Gay CL, Lerdal A. Lack of content overlap and essential dimensions–A review of measures used for post-stroke fatigue. J Psychosom Res. 2019;124:109759.
30. Falup-Pecurariu C. Fatigue assessment of Parkinson’s disease patient in clinic: Specific versus holistic. Journal of Neural Transmission. 2013;120(4):577-81.
31. Mead G, Lynch J, Greig C, Young A, Lewis S, Sharpe M. Evaluation of fatigue scales in stroke patients. Stroke. 2007;38(7):2090-5.
32. Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007;30(1):81-5. Epub 2007/02/13. doi: 10.1097/MRR.0b013e3280146ec4. PubMed PMID: 17293726.
33. Ozyemisci-Taskiran O, Batur EB, Yuksel S, Cengiz M, Karatas GK. Validity and reliability of fatigue severity scale in stroke. Top Stroke Rehabil. 2019;26(2):122-7.
34. Ozturk EA, Gonenli Kocer B, Gundogdu I, Umay E, Cakci FA. Reliability and validity study of a Turkish version of the fatigue severity scale in Parkinson’s disease patients. Int J Rehabil Res. 2017;40(2):185-90. Epub 2017/03/18. doi: 10.1097/mrr.0000000000000224. PubMed PMID: 28306619.
35. Anton HA, Miller WC, Townson AF. Measuring fatigue in persons with spinal cord injury. Arch Phys Med Rehabil. 2008;89(3):538-42.
36. Selvi Y, Gulec M, Aydin A, Besiroglu L. Psychometric evaluation of the Turkish language version of the Profile of Mood States (POMS). Journal of Mood Disorders. 2011;1(4):152-61.
37. Çinar D, Yava A. Validity and reliability of functional assessment of chronic illness treatment-fatigue scale in Turkish patients with type 2 diabetes. Endocrinología, Diabetes y Nutrición (English ed). 2018;65(7):409-17. doi: https://doi.org/10.1016/j.endien.2018.07.001.
38. Butt Z, Lai JS, Rao D, Heinemann AW, Bill A, Cella D. Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) scale. J Psychosom Res. 2013;74(1):64-8. Epub 2013/01/01. doi: 10.1016/j. jpsychores.2012.10.011. PubMed PMID: 23272990; PubMed Central PMCID: PMCPMC3534851.
39. Hagell P, Höglund A, Reimer J, Eriksson B, Knutsson I, Widner H, et al. Measuring fatigue in Parkinson’s disease: A psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage. 2006;32(5):420-32. doi: https://doi.org/10.1016/j. jpainsymman.2006.05.021.
40. Çilga G, Genç A, Çolakoglu BD, Kahraman T. Turkish adaptation of Parkinson fatigue scale and investigating its psychometric properties. Int J Rehabil Res. 2019;42(1):20-5. doi: 10.1097/mrr.0000000000000314. PubMed PMID: 00004356-201903000-00003.
41. Ozturk EA, Kocer BG, Umay E, Cakci A. Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale. Qual Life Res. 2018;27(10):2719-30. Epub 2018/06/09. doi: 10.1007/s11136-018-1907-3. PubMed PMID: 29881896.
42. Öztürk EA, Koçer BG, Umay E, Çakcı A. Turkish version of Parkinson Fatigue Scale: Validity and reliability study of binary scoring method. Turk J Phys Med Rehabil. 2018;64(3):253-60.
43. Armutlu K, Keser I, Korkmaz N, Akbiyik DI, Sümbüloğlu V, Güney Z, et al. Psychometric study of Turkish version of Fatigue Impact Scale in multiple sclerosis patients. J Neurol Sci. 2007;255(1-2):64-8. Epub 2007/03/06. doi: 10.1016/j.jns.2007.01.073. PubMed PMID: 17337007.
44. Parks NE, Eskes GA, Gubitz GJ, Reidy Y, Christian C, Phillips SJ. Fatigue impact scale demonstrates greater fatigue in younger stroke survivors. Can J Neurol Sci. 2012;39(5):619-25. Epub 2012/08/31. doi: 10.1017/ s0317167100015353. PubMed PMID: 22931703.
45. Yildirim Y, Ergin G. A validity and reliability study of the Turkish Multidimensional Assessment of Fatigue (MAF) scale in chronic musculoskeletal physical therapy patients. J Back Musculoskelet Rehabil. 2013;26:307-16. doi: 10.3233/BMR-130385.
46. Lequerica A, Bushnik T, Wright J, Kolakowsky-Hayner SA, Hammond FM, Dijkers MP, et al. Psychometric properties of the Multidimensional Assessment of Fatigue scale in traumatic brain injury: An NIDRR Traumatic Brain Injury Model Systems study. J Head Trauma Rehabil. 2012;27(6):E28-E35.
47. Ergin G, Yildirim Y. A validity and reliability study of the Turkish Checklist Individual Strength (CIS) questionnaire in musculoskeletal physical therapy patients. Physiother Theory Pract. 2012;28(8):624-32.Epub 2012/02/14. doi: 10.3109/09593985.2011.654321. PubMed PMID: 22324761.
48. Rietberg M, Van Wegen E, Kwakkel G. Measuring fatigue in patients with multiple sclerosis: Reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires. Disabil Rehabil. 2010;32(22):1870-6.
49. Başoğlu F, Öncü J, Kuran B, Alptekin HK. The reliability and validity of The Turkish version of Multidimensional Fatigue Inventory-20 for the evaluation of different dimensions of fatigue in patients with fibromyalgia. Turk J Phys Med Rehabil. 2020;66(4):436-43. doi: 10.5606/ tftrd.2020.5781. PubMed PMID: 33364564.
50. Elbers RG, van Wegen EE, Verhoef J, Kwakkel G. Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) inpatients with idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(5):532-6.
51. Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF, Terwee CB, et al. Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: A systematic review of measurement properties. Quality of Life Research. 2012;21(6):925-44.
52. Benito-León J, Martínez-Martín P, Frades B, Martínez-Ginés ML, de Andrés C, Meca-Lallana JE, et al. Impact of fatigue in multiple sclerosis: The Fatigue Impact Scale for Daily Use (D-FIS). Multiple Sclerosis Journal. 2007;13(5):645-51. doi: 10.1177/1352458506073528. PubMed PMID: 17548445.
53. Manoli R, Chartaux-Danjou L, Delecroix H, Daveluy W, Moroni C. Is Multidimensional Fatigue Inventory (MFI-20) adequate to measure brain injury related fatigue? Disabil Health J. 2020;13(3):100913. doi: https://doi.org/10.1016/j.dhjo.2020.100913.
54. Alghwiri AA, Almhdawi KA, Marchetti G. Are fatigue scales the same? A content comparison using the International Classification of Functioning, Disability and Health. Mult Scler Relat Disord. 2020;46:102596.
55. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121-3.
56. Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat Disord. 2005;11(1):49-55. doi: https://doi. org/10.1016/j.parkreldis.2004.07.007.
57. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clinical Infectious Diseases. 1994;18(Supplement_1):S79-S83.
58. Mills RJ, Young CA, Pallant JF, Tennant A. Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). Health Qual Life Outcomes. 2010;8(1):22.
59. Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Development of a patient reported outcome measure for fatigue in motor neurone disease: The Neurological Fatigue Index (NFI-MND). Health Qual Life Outcomes. 2011;9(1):101. doi: 10.1186/1477-7525-9- 101.
60. Mills RJ, Pallant JF, Koufali M, Sharma A, Day S, Tennant A, et al. Validation of the Neurological Fatigue Index for stroke (NFI-Stroke). Health Qual Life Outcomes. 2012;10(1):51. doi: 10.1186/1477-7525-10- 51.
61. Kittiwatanapaisan W, Gauthier DK, Williams AM, Oh SJ. Fatigue in myasthenia gravis patients. Journal of Neuroscience Nursing. 2003;35(2):87-106. PubMed PMID: 01376517-200304000-00004.
62. Shair E, Ahmad SA, Marhaban M, Mohd Tamrin S, Abdullah A. EMG processing based measures of fatigue assessment during manual lifting. BioMed Research International. 2017;2017. https://doi. org/10.1155/2017/3937254
63. Toro SFd, Santos-Cuadros S, Olmeda E, Álvarez-Caldas C, Díaz V, San Román JL. Is the use of a low-cost sEMG sensor valid to measure muscle fatigue? Sensors. 2019;19(14):3204.
64. Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiological Reviews. 2001;81(4).
65. Mugnosso M, Marini F, Gillardo M, Morasso P, Zenzeri J, editors. A novel method for muscle fatigue assessment during robot-based tracking tasks. 2017 International Conference on Rehabilitation Robotics (ICORR); 2017: IEEE.